Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 3 days agoThe deal is a negative for Covid vaccine rivals Pfizer and Moderna, Leerink Partners analyst David...
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam? - Pfizer...
Benzinga· 4 days agoClair, a contributor to satirical outlet The Babylon Bee, shared a blog post. The post alleged the...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 4 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 7 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
AI Tool Predicts Whether Online Health Misinformation Will Cause Real-World Harm
Scientific American· 5 hours agoThe flood of misinformation online inevitably produces adverse consequences in key measures of...
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
Benzinga· 4 days agoSaint-Herblain (France), May 13, 2024 – Valneva SE VALNVLA, a specialty vaccine company, today reported further positive pivotal Phase 3 data in adolescents for its single-shot ...
Political Watch: December 2, 2021
Santa Maria Sun· 2 days agoBatjer has served as president for the commission since 2019 and previously served as the first ever secretary of the California Government Operations Agency. “As my lead energy...
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 3 days agoSHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV ...